The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
The National Academies of Sciences, Engineering, and Medicine (NASEM) will convene an ad hoc planning committee to organize a workshop series with international scientists. The series will engage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results